|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Stein JP, Lieskovsky G, Cote R, et al:
Radical cystectomy in the treatment of invasive bladder cancer:
long-term results in 1,054 patients. J Clin Oncol. 19:666–675.
2001.PubMed/NCBI
|
|
3
|
Messing E: Urothelial tumors of the
bladder. Campbell-Walsh Urology. Wein AJ: 9th edition. Saunders
Elsevier; Philadelphia: pp. 2407–2446. 2007
|
|
4
|
Shariat SF, Karakiewicz PI, Palapattu GS,
et al: Outcomes of radical cystectomy for transitional cell
carcinoma of the bladder: a contemporary series from the Bladder
Cancer Research Consortium. J Urol. 176:2414–2422. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Madeb R and Messing EM: Gender, racial and
age differences in bladder cancer incidence and mortality. Urol
Oncol. 22:86–92. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tilki D, Svatek RS, Karakiewicz PI, et al:
Characteristics and outcomes of patients with pT4 urothelial
carcinoma at radical cystectomy: a retrospective international
study of 583 patients. J Urol. 183:87–93. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
May M, Bastian PJ, Brookman-May S, et al:
Gender-specific differences in cancer-specific survival after
radical cystectomy for patients with urothelial carcinoma of the
urinary bladder in pathologic tumor stage T4a. Urol Oncol. Nov
4–2011.(Epub ahead of print).
|
|
8
|
Palou J, Sylvester RJ, Faba OR, et al:
Female gender and carcinoma in situ in the prostatic urethra are
prognostic factors for recurrence, progression, and
disease-specific mortality in T1G3 bladder cancer patients treated
with bacillus Calmette-Guérin. Eur Urol. 62:118–125. 2012.
|
|
9
|
Scosyrev E, Noyes K, Feng C and Messing E:
Sex and racial differences in bladder cancer presentation and
mortality in the US. Cancer. 115:68–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shariat SF, Chromecki TF, Cha EK, et al:
Risk stratification of organ-confined bladder cancer after radical
cystectomy using cell cycle-related biomarkers. J Urol.
187:457–462. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tilki D, Reich O, Svatek RS, et al:
Characteristics and outcomes of patients with clinical carcinoma in
situ only treated with radical cystectomy: an international study
of 243 patients. J Urol. 183:1757–1763. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tilki D, Svatek RS, Novara G, et al: Stage
pT0 at radical cystectomy confers improved survival: an
international study of 4,430 patients. J Urol. 184:888–894. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Rhijn BW, van der Kwast TH, Alkhateeb
SS, et al: A new and highly prognostic system to discern T1 bladder
cancer substage. Eur Urol. 61:378–384. 2012.
|
|
14
|
Imamov O, Yakimchuk K, Morani A, et al:
Estrogen receptor beta-deficient female mice develop a bladder
phenotype resembling human interstitial cystitis. Proc Natl Acad
Sci USA. 104:9806–9809. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
May M, Stief C, Brookman-May S, et al:
Gender-dependent cancer-specific survival following radical
cystectomy. World J Urol. 30:707–713. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Davis-Dao CA, Henderson KD,
Sullivan-Halley J, et al: Lower risk in parous women suggests that
hormonal factors are important in bladder cancer etiology. Cancer
Epidemiol Biomarkers Prev. 20:1156–1170. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McGrath M, Michaud DS and De Vivo I:
Hormonal and reproductive factors and the risk of bladder cancer in
women. Am J Epidemiol. 163:236–244. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Prizment AE, Anderson KE, Harlow BL and
Folsom AR: Reproductive risk factors for incident bladder cancer:
Iowa Women’s Health Study. Int J Cancer. 120:1093–1098. 2007.
|
|
19
|
Thomas C and Gustafsson JA: The different
roles of ER subtypes in cancer biology and therapy. Nat Rev Cancer.
11:597–608. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim HT, Kim BC, Kim IY, et al: Raloxifene,
a mixed estrogen agonist/antagonist, induces apoptosis through
cleavage of BAD in TSU-PR1 human cancer cells. J Biol Chem.
277:32510–32515. 2002. View Article : Google Scholar
|
|
21
|
Pu YS, Hsieh TS, Cheng AL, et al: Combined
cytotoxic effects of tamoxifen and chemotherapeutic agents on
bladder cancer cells: a potential use in intravesical chemotherapy.
Br J Urol. 77:76–85. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shen SS, Smith CL, Hsieh JT, et al:
Expression of estrogen receptors-α and -β in bladder cancer cell
lines and human bladder tumor tissue. Cancer. 106:2610–2616.
2006.
|
|
23
|
Sonpavde G, Okuno N, Weiss H, et al:
Efficacy of selective estrogen receptor modulators in nude mice
bearing human transitional cell carcinoma. Urology. 69:1221–1226.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kontos S, Papatsoris A, Kominea A, et al:
Expression of ERβ and its co-regulators p300 and NCoR in human
transitional cell bladder cancer. Urol Int. 87:151–158. 2011.
|
|
25
|
Kontos S, Kominea A, Melachrinou M,
Balampani E and Sotiropoulou-Bonikou G: Inverse expression of
estrogen receptor-β and nuclear factor-κB in urinary bladder
carcinogenesis. Int J Urol. 17:801–809. 2010.
|
|
26
|
Tuygun C, Kankaya D, Imamoglu A, et al:
Sex-specific hormone receptors in urothelial carcinomas of the
human urinary bladder: a comparative analysis of
clinicopathological features and survival outcomes according to
receptor expression. Urol Oncol. 29:43–51. 2011. View Article : Google Scholar
|
|
27
|
Kauffman EC, Robinson BD, Downes MJ, et
al: Role of androgen receptor and associated lysine-demethylase
coregulators, LSD1 and JMJD2A, in localized and advanced human
bladder cancer. Mol Carcinog. 50:931–944. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Teng J, Wang ZY, Jarrard DF and Bjorling
DE: Roles of estrogen receptor α and β in modulating urothelial
cell proliferation. Endocr Relat Cancer. 15:351–364. 2008.
|
|
29
|
Han B, Cui D, Jing Y, Hong Y and Xia S:
Estrogen receptor β (ERβ ) is a novel prognostic marker of
recurrence survival in non-muscle-invasive bladder cancer
potentially by inhibiting cadherin switch. World J Urol.
30:861–867. 2012.
|
|
30
|
Miyamoto H, Yao JL, Chaux A, et al:
Expression of androgen and oestrogen receptors and its prognostic
significance in urothelial neoplasm of the urinary bladder. BJU
Int. 109:1716–1726. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Waliszewski P, Waliszewska MK, Hemstreet
GP III and Hurst RE: Expression of sex steroid receptor genes and
comodulation with retinoid signaling in normal human uroepithelial
cells and bladder cancer cell lines. Urol Oncol. 3:141–147. 1997.
View Article : Google Scholar : PubMed/NCBI
|
